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LETTER TO THE EDITOR
Constitutional frequencies of c-Ha-ras alleles in patients with different
types of lung cancer
Sir - In a study of constitutional restriction fragment length
polymorphisms at the HRAS1 locus in patients with small
cell (SCLC) and non-small cell cancer (NSCLC) of the lung
and in a control group we reported earlier differences in the
distribution of the common alleles between these three
groups (Heighway et al., 1986). The main difference was a
relative increase of the number of individuals carrying the a4
allele among NSCLC patients (19/66, i.e. 29%) compared
with the control group (15/101, i.e. 15%, P <0.05). Patients
with SCLC showed a slight decrease in the frequency of this
allele (5/66, i.e. 8%, P <0.004 compared with the group of
NSCLC patients). We suggested that the allele status may
confer a genetic predisposition to a particular type of lung
cancer.
In order to test the reproducibility of those results we
analysed a new set of 238 patients. The only difference
between both studies is that in the present one the DNA was
exclusively extracted from peripheral blood, whereas in the
first study in some cases only tumour material was used. The
present results do not show, at a probability level of 0.05,
any significant difference between the three groups in the
allele frequencies (Table I) or in the proportions of individ-
uals carrying the a4 allele (Table II).
Our new data fail to support the hypothesis that certain
c-Ha-ras alleles are involved in a genetic predisposition to
certain types of lung cancer.
Table II Individuals carrying the a4 allele
Controls 15/101 (15%)
SCLC patients 18/137 (13%)
NSCLC patients 13/101 (13%)
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Table I Allele distribution of c-Ha-ras in 238 patients with small cell (SCLC) and non-small cell cancer
(NSCLC) of the lung
Allele type
al a2 a3 a4 Rare Total
SCLC 172 (63%) 33 (12%) 34 (12%) 18 (7%) 17 (6%) 274
NSCLC 124 (61%) 26 (13%) 30 (15%) 14 (7%) 7 (3%) 202
Controls 120 (60%) 32 (16%) 26 (13%) 15 (7%) 9 (4%) 202
The data for the control group were taken from Heighway et al. (1986). The alleles were determined using
Pvu II digests of genomic DNA and the probe pT24-C3 (Reddy et al. 1982).
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